Comparison of clinical outcomes in patients treated with indigenous (Indian) versus FDA approved/CE marked drug eluting stents (DES)

Comparison of clinical outcomes in patients treated with indigenous (Indian) versus FDA approved/CE marked drug eluting stents (DES)

Bibliographic Details
Main Authors:	Naresh K. Goyal, Rakesh K. Jaswal, Rajat Sharma
Format:	Article
Language:	English
Published:	Elsevier 2017-11-01
Series:	Indian Heart Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483217307332

Similar Items

FDA, CE mark or something else?—Thinking fast and slow
by: Sundeep Mishra
Published: (2017-01-01)

FDA approved ready to use phenylephrine
by: Pradeep Kumar Bhatia, et al.
Published: (2021-01-01)

FDA approves Opdivo to treat advanced form of kidney cancer
by: - -
Published: (2015-12-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
by: Becky A. S. Bibby, et al.
Published: (2021-07-01)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
by: Nisha Ohri, MD, et al.
Published: (2016-01-01)

Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center
by: Jerin M, et al.
Published: (2012-04-01)

Why did the FDA approve these advertisements?
by: David Oaks
Published: (2006-02-01)

Announcement Effect of Drug Approvals by FDA
by: Ting, Hsiu Wen, et al.
Published: (2008)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
by: Negar Faramarzi, et al.
Published: (2015-10-01)

Study to assess clinical outcomes of an everolimus-eluting stent (EES) versus a sirolimus-eluting stent (SES)
by: Amit Madaan, et al.
Published: (2015-12-01)

Widowmaker Right Coronary Artery Treated With Drug-Eluting Stent Implantation
by: Gurpreet Singh, MD, et al.
Published: (2019-10-01)

Antibiotic eluting sinus stents
by: Harrison M. Thompson, et al.
Published: (2020-08-01)

Drug-eluting stent in diabetes
by: Hernani Pinto de Lemos Júnior, et al.

Everolimus-eluting coronary stents
by: Alejandro Saez, et al.
Published: (2010-09-01)

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

A modern generation of drug-eluting stents. Focusing on a sirolimus-eluting stent Calypso
by: А. Н. Кудряшов, et al.
Published: (2017-04-01)

Quantitative analysis on the characteristics of targets with FDA approved drugs
by: Meena K. Sakharkar, Peng Li, Zhaowei Zhong, Kishore R. Sakharkar
Published: (2008-01-01)

Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection
by: Ashwini eBenedict, et al.
Published: (2015-07-01)

THPdb: Database of FDA-approved peptide and protein therapeutics.
by: Salman Sadullah Usmani, et al.
Published: (2017-01-01)

Coronary angioplasty in unprotected left main disease with indigenous sirolinus eluting biodegradable polymer Yukon choice flex stent
by: S. Lahiri, et al.
Published: (2015-12-01)

Different patterns of in-stent coverage in drug-eluting stents
by: Daniele Gemma, et al.
Published: (2017-11-01)

Different patterns of in-stent coverage in drug-eluting stents
by: Daniele Gemma, et al.
Published: (2017-11-01)

Stent Fracture after Everolimus-Eluting Stent Implantation
by: Ali S. Almasood, et al.
Published: (2011-01-01)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
by: Wen-Juan Xiu, et al.
Published: (2018-01-01)

Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting
by: Vogt A, et al.
Published: (2011-11-01)

Two-year results of an open-label randomized comparison of everolimus-eluting stents and sirolimus-eluting stents.
by: Matthijs A Velders, et al.
Published: (2014-01-01)

The current landscape of the FDA approved companion diagnostics
by: Jan Trøst Jørgensen
Published: (2021-06-01)

Everolimus-eluting stents in interventional cardiology
by: Townsend JC, et al.
Published: (2012-06-01)

Drug-eluting metallic stents in urology
by: Panagiotis S Kallidonis, et al.
Published: (2014-01-01)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
by: Matthijs A. Velders, et al.
Published: (2013-01-01)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
by: Ryota Kakizaki, et al.
Published: (2020-10-01)

Paclitaxel-eluting stent (PES) versus everolimus-eluting stent (EES) in insulin requiring diabetics – Are the results different?
by: U. Kaul, et al.
Published: (2015-12-01)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents.
by: Matthijs A. Velders, et al.
Published: (2013-01-01)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
by: Ahmad Separham, et al.
Published: (2011-11-01)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
by: Alaide Chieffo, et al.
Published: (2007-09-01)

Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer
by: Liyan Yang, et al.
Published: (2021-06-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
by: Matthew G. Whitbeck, et al.
Published: (2013-07-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
by: Matthew G. Whitbeck, et al.
Published: (2013-01-01)

Clinical results of indigenous biodegradable polymer sirolimus eluting Yukon Choice Flex stent in all comer patients with coronary artery disease
by: P. Nayak, et al.
Published: (2015-12-01)